Vyant Bio Inc expected to post a loss of 70 cents a share - Earnings Preview

Vyant Bio

08/11/2022 03:05

* Vyant Bio Inc  VYNT.OQ   VYNT.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 9
(estimated). 
    * The Cherry Hill New Jersey-based  company is expected to
report 
a 95.3% decrease in revenue to $70.5 thousand from $1.51 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vyant Bio Inc is
for a
loss of 70 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$12.2​, above​ its last closing price of $1.54. ​​​

This summary was machine generated November 8 at 03:05 GMT.  All
figures in US dollars  unless otherwise stated